Spots Global Cancer Trial Database for raeb
Every month we try and update this database with for raeb cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA | NCT02562443 | Myelodysplastic... MDS Refractory Anem... RAEB | rigosertib Any approved or... best supportive... best supportive... | 18 Years - 81 Years | Traws Pharma, Inc. | |
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA | NCT02562443 | Myelodysplastic... MDS Refractory Anem... RAEB | rigosertib Any approved or... best supportive... best supportive... | 18 Years - 81 Years | Traws Pharma, Inc. | |
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts | NCT01241500 | Myelodysplastic... MDS RAEB Chronic Myelomo... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. |